Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: ...

Women with a higher risk of developing breast cancer are set to be offered a pill that cuts their risk of developing the disease in half. NHS England and UK medication watchdogs announced the pill ...

Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Postmenopausal women with ductal carcinoma in situ experienced comparable rates of recurrence but ...

Please provide your email address to receive an email when new articles are posted on . Adding the ER antagonist fulvestrant to anastrozole provided no benefit to women with hormone-receptor-positive ...

September 8, 2008 — The foveas of women using anastrozole to prevent breast cancer recurrence appear to be subjected to more tractional force than the foveas of women not using any hormonal medication ...

A drug previously used to treat breast cancer is now being offered to high risk women as a preventative measure. It has previously been used to treat breast cancer but has been “repurposed” to prevent ...

Faslodex (fulvestrant) improved overall survival by nearly six months compared with anastrozole as initial hormone therapy for postmenopausal women with estrogen receptor-positive advanced breast ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Carpal tunnel ...

Enclomiphene is a non-steroidal selective estrogen receptor modulator (SERM) sometimes used to treat male secondary hypogonadism, or low testosterone caused by problems with the hypothalamus or ...

Almost 300,000 women are to be offered a drug to reduce their risk of developing breast cancer, NHS officials have announced. Anastrozole has previously been used to treat hormone-sensitive breast ...

Waldenström's macroglobulinemia is a lymphoproliferative disorder characterized by a lymphoplasmacytic bone marrow infiltrate and high levels of a monoclonal IgM in serum. 1 A number of ...